NYSE: HNGE
Hinge Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for HNGE

Based on 14 analysts offering 12 month price targets for Hinge Health Inc

Min Forecast
$41.00-19.2%
Avg Forecast
$57.43+13.18%
Max Forecast
$67.00+32.05%

Should I buy or sell HNGE stock?

Based on 14 analysts offering ratings for Hinge Health Inc.

Strong Buy
Strong Buy
8 analysts 57.14%
Buy
5 analysts 35.71%
Hold
1 analysts 7.14%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HNGE's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HNGE as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their HNGE stock forecasts and price targets.

HNGE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-08
lockedlocked$00.00+00.00%2025-09-23Find Out Why
lockedlocked$00.00+00.00%2025-09-11Find Out Why
lockedlocked$00.00+00.00%2025-09-05
lockedlocked$00.00+00.00%2025-08-06
JMP Securities
Bottom 12%
12
BuyMaintains$65.00+28.10%2025-08-06
Barclays
Top 3%
98
Strong BuyMaintains$62.00+22.19%2025-08-06
Needham
Top 17%
84
BuyMaintains$59.00+16.28%2025-08-06
Bank of America
Top 7%
94
Strong BuyMaintains$64.00+26.13%2025-08-06Find out why
KeyBanc
Bottom 6%
6
Strong BuyMaintains$60.00+18.25%2025-07-14

1 of 2

Forecast return on equity

Is HNGE forecast to generate an efficient return?

Company
N/A
Industry
16.73%
Market
-61.61%

Forecast return on assets

Is HNGE forecast to generate an efficient return on assets?

Company
N/A
Industry
13.18%

HNGE earnings per share forecast

What is HNGE's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$6.04
Avg 2 year Forecast
$0.24
Avg 3 year Forecast
$0.26

HNGE revenue forecast

What is HNGE's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$551.1M
Avg 2 year Forecast
$650.5M
Avg 3 year Forecast
$754.8M

HNGE vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
HNGE$50.74$57.43+13.18%Strong Buy
WGS$118.42$108.00-8.80%Strong Buy
PRVA$25.53$28.83+12.94%Buy
HTFL$33.47$37.00+10.55%Strong Buy
BTSG$29.45$32.75+11.21%Strong Buy

Hinge Health Stock Forecast FAQ

Is Hinge Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NYSE: HNGE) stock is to Strong Buy HNGE stock.

Out of 14 analysts, 8 (57.14%) are recommending HNGE as a Strong Buy, 5 (35.71%) are recommending HNGE as a Buy, 1 (7.14%) are recommending HNGE as a Hold, 0 (0%) are recommending HNGE as a Sell, and 0 (0%) are recommending HNGE as a Strong Sell.

If you're new to stock investing, here's how to buy Hinge Health stock.

What is HNGE's earnings growth forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 18.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16%.

Hinge Health's earnings in 2025 is N/A.On average, 2 Wall Street analysts forecast HNGE's earnings for 2025 to be -$473,356,716, with the lowest HNGE earnings forecast at -$489,435,941, and the highest HNGE earnings forecast at -$457,277,490. On average, 2 Wall Street analysts forecast HNGE's earnings for 2026 to be $18,432,283, with the lowest HNGE earnings forecast at $3,921,762, and the highest HNGE earnings forecast at $32,942,804.

In 2027, HNGE is forecast to generate $20,000,988 in earnings, with the lowest earnings forecast at $3,137,410 and the highest earnings forecast at $36,864,566.

What is HNGE's revenue growth forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's forecast annual revenue growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.9%.

Hinge Health's revenue in 2025 is N/A.On average, 6 Wall Street analysts forecast HNGE's revenue for 2025 to be $43,228,802,032, with the lowest HNGE revenue forecast at $43,060,950,603, and the highest HNGE revenue forecast at $43,539,405,610. On average, 7 Wall Street analysts forecast HNGE's revenue for 2026 to be $51,023,069,396, with the lowest HNGE revenue forecast at $48,041,588,788, and the highest HNGE revenue forecast at $52,661,424,836.

In 2027, HNGE is forecast to generate $59,205,120,623 in revenue, with the lowest revenue forecast at $55,547,841,925 and the highest revenue forecast at $63,203,122,033.

What is HNGE's forecast return on assets (ROA) for 2025-2028?

(NYSE: HNGE) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 13.18%.

What is HNGE's Price Target?

According to 14 Wall Street analysts that have issued a 1 year HNGE price target, the average HNGE price target is $57.43, with the highest HNGE stock price forecast at $67.00 and the lowest HNGE stock price forecast at $41.00.

On average, Wall Street analysts predict that Hinge Health's share price could reach $57.43 by Oct 8, 2026. The average Hinge Health stock price prediction forecasts a potential upside of 13.18% from the current HNGE share price of $50.74.

What is HNGE's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that HNGE's EPS will be -$6.04 for 2025, with the lowest EPS forecast at -$6.24, and the highest EPS forecast at -$5.83. On average, analysts forecast that HNGE's EPS will be $0.24 for 2026, with the lowest EPS forecast at $0.05, and the highest EPS forecast at $0.42. In 2027, HNGE's EPS is forecast to hit $0.26 (min: $0.04, max: $0.47).

What is HNGE's forecast return on equity (ROE) for 2025-2028?

(NYSE: HNGE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.